These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9539407)
1. Superoxide dismutase activity in cerebrospinal fluid of patients with dementia and some other neurological disorders. De Deyn PP; Hiramatsu M; Borggreve F; Goeman J; D'Hooge R; Saerens J; Mori A Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):26-32. PubMed ID: 9539407 [TBL] [Abstract][Full Text] [Related]
2. Cu, Zn superoxide dismutase in patients with dementia of the Alzheimer type. Urakami K; Sato K; Okada A; Mura T; Shimomura T; Takenaka T; Wakutani Y; Oshima T; Adachi Y; Takahashi K Acta Neurol Scand; 1995 Mar; 91(3):165-8. PubMed ID: 7793229 [TBL] [Abstract][Full Text] [Related]
3. Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia. Ihara Y; Hayabara T; Sasaki K; Fujisawa Y; Kawada R; Yamamoto T; Nakashima Y; Yoshimune S; Kawai M; Kibata M; Kuroda S J Neurol Sci; 1997 Dec; 153(1):76-81. PubMed ID: 9455982 [TBL] [Abstract][Full Text] [Related]
4. Increased superoxide dismutase activity in aged human cerebrospinal fluid and rat brain determined by electron spin resonance spectrometry using the spin trap method. Hiramatsu M; Kohno M; Edamatsu R; Mitsuta K; Mori A J Neurochem; 1992 Mar; 58(3):1160-4. PubMed ID: 1310721 [TBL] [Abstract][Full Text] [Related]
5. Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging. de Lustig ES; Serra JA; Kohan S; Canziani GA; Famulari AL; Dominguez RO J Neurol Sci; 1993 Mar; 115(1):18-25. PubMed ID: 8468588 [TBL] [Abstract][Full Text] [Related]
6. Superoxide dismutase activity in cerebrospinal fluid and its relation to compression of the lumbosacral nerve root. Tamada T; Inoue H; Mori A Acta Med Okayama; 1996 Aug; 50(4):197-201. PubMed ID: 8874581 [TBL] [Abstract][Full Text] [Related]
7. [Superoxide dismutase in cerebrospinal fluid in patients with neurological diseases]. Yoshida E; Mokuno K; Aoki S; Takahashi A; Kato K Rinsho Shinkeigaku; 1993 Jan; 33(1):21-6. PubMed ID: 8334770 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of decreased superoxide dismutase 1 in patients with epilepsy. Chen D; Lu Y; Yu W; Luo J; Xiao Z; Xiao F; Wang X Seizure; 2012 Sep; 21(7):508-11. PubMed ID: 22652071 [TBL] [Abstract][Full Text] [Related]
9. Aging and superoxide dismutase activity in cerebrospinal fluid. Okabe T; Hamaguchi K; Inafuku T; Hara M J Neurol Sci; 1996 Sep; 141(1-2):100-4. PubMed ID: 8880700 [TBL] [Abstract][Full Text] [Related]
10. Increase in superoxide dismutase after cerebrovascular accident. Gruener N; Gross B; Gozlan O; Barak M Life Sci; 1994; 54(11):711-3. PubMed ID: 8107520 [TBL] [Abstract][Full Text] [Related]
11. Human aging brain disorders: role of antioxidant enzymes. de la Torre MR; Casado A; López-Fernández ME; Carrascosa D; Casado MC; Venarucci D; Venarucci V Neurochem Res; 1996 Aug; 21(8):885-8. PubMed ID: 8895840 [TBL] [Abstract][Full Text] [Related]
12. [Alterations in neurotransmitter, amino acid and free radical related substances in cerebrospinal fluid in patients with cerebrovascular diseases]. Egashira T; Goto H; Takeda H; Takada K; Matsumiya T Nihon Ronen Igakkai Zasshi; 1999 Apr; 36(4):256-61. PubMed ID: 10410569 [TBL] [Abstract][Full Text] [Related]
13. [Decreased antioxidant-defence mechanisms in cerebrospinal fluid (CSF) in patients with tick-borne encephalitis (TBE)]. Pancewicz SA; Hermanowska-Szpakowicz T; Makarewicz-Płońska M; Witek A; Farbiszewski R; Zajkowska J; Michalska B Neurol Neurochir Pol; 2002; 36(4):767-76. PubMed ID: 12418140 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type. Atack JR; May C; Kaye JA; Kay AD; Rapoport SI Ann Neurol; 1988 Feb; 23(2):161-7. PubMed ID: 3377438 [TBL] [Abstract][Full Text] [Related]
15. Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia. Danielczyk W; Streifler M; Konradi C; Riederer P; Moll G Acta Psychiatr Scand; 1988 Dec; 78(6):730-6. PubMed ID: 3223331 [TBL] [Abstract][Full Text] [Related]
17. Superoxide dismutase activity in cisternal cerebrospinal fluid after aneurysmal subarachnoid haemorrhage. Gaetani P; Cafe C; Rodriguez y Baena R; Tancioni F; Torri C; Tartara F; Marzatico F Acta Neurochir (Wien); 1997; 139(11):1033-7. PubMed ID: 9442216 [TBL] [Abstract][Full Text] [Related]
18. Raised nitrate concentration and low SOD activity in the CSF of sporadic ALS patients. Boll MC; Alcaraz-Zubeldia M; Montes S; Murillo-Bonilla L; Rios C Neurochem Res; 2003 May; 28(5):699-703. PubMed ID: 12716019 [TBL] [Abstract][Full Text] [Related]
19. Relationship between oxidative stress and apoE phenotype in Alzheimer's disease. Ihara Y; Hayabara T; Sasaki K; Kawada R; Nakashima Y; Kuroda S Acta Neurol Scand; 2000 Dec; 102(6):346-9. PubMed ID: 11125747 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]